Product Information
METHYLPHENIDATE ER(LA) 30 MG CP is a generic product labeled by Sandoz Inc., priced at $2.0321 per EA under NDC 00781238501. Its NADAC has been published 48 times since Jul 30, 2025.
Strength
30 mg/1
Manufacturer
Sandoz Inc.NDC
00781238501
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021284On Market Since
11/24/2015
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE ER(LA) 30 MG CP has been published 48 times since Jul 30, 2025, and over the history we have for it it has declined 16.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0321 per EA |
|---|---|
| All-time high | $2.9073 (Dec 10, 2025) |
| All-time low | $2.0321 (Jun 17, 2026) |
| 52-week high | $2.9073 |
| 52-week low | $2.0321 |
| Median price | $2.2328 |
| Average price | $2.3174 |
| Largest weekly change | +16.7% (Oct 22, 2025) |
| Weeks tracked | 48 |
| Tracking since | Jul 30, 2025 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE ER(LA) 30 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER(LA) 30 MG CP, manufactured by Sandoz Inc., is $2.0321 per EA (NDC 00781238501), effective Jun 24, 2026.
How has the price of METHYLPHENIDATE ER(LA) 30 MG CP changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE ER(LA) 30 MG CP has declined 16.6%. It has been tracked across 48 weekly CMS publications since Jul 30, 2025.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER(LA) 30 MG CP?
Since Jul 30, 2025, the NADAC for METHYLPHENIDATE ER(LA) 30 MG CP has ranged from a low of $2.0321 (Jun 17, 2026) to a high of $2.9073 (Dec 10, 2025), with a median of $2.2328 per EA.
Are there cheaper alternatives to METHYLPHENIDATE ER(LA) 30 MG CP?
2 NADAC-published products share the same active ingredient, strength, and dosage form as METHYLPHENIDATE ER(LA) 30 MG CP, but none are currently priced below it.
Who manufactures METHYLPHENIDATE ER(LA) 30 MG CP?
METHYLPHENIDATE ER(LA) 30 MG CP (NDC 00781238501) is labeled by Sandoz Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification